GeneOne Life Science Inc (011000) — Capital Reinvestment Ratio

Latest as of December 2021: 9.66x

GeneOne Life Science Inc (011000) has a Capital Reinvestment Ratio of 9.66x as of December 2021, meaning it reinvests 10% of its operating cash flow (₩3.67 Billion) in capital expenditures (₩35.40 Billion). Check tangible net worth ratio of GeneOne Life Science Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

9.66x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.67 Billion
KRW

Capital Expenditures

₩35.40 Billion
KRW

Data as of

Dec 2021
Most recent filing

GeneOne Life Science Inc Capital Reinvestment Ratio (2015–2015)

This chart tracks GeneOne Life Science Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 011000 cash flow conversion.

Annual Capital Reinvestment Ratio for GeneOne Life Science Inc (2015–2015)

Year-by-year Capital Reinvestment Ratio for GeneOne Life Science Inc from 2015 to 2015. See 011000 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2015 2.62x ₩778.50 Million ₩2.04 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow